2001-Thu Feb 23 04:45:03 EST 2017
Vetstreet. All rights reserved.
Vetstreet does not provide medical advice, diagnosis, or treatment. See Additional Information ›
Sponsored content from
This content was created by our sponsor. This is not subject to the Vetstreet Editorial Policy and is not reviewed by the Vetstreet editorial department for accuracy, objectivity or balance.
Motion sickness is a stressful condition that affects 1 out of every 5 dogs,
1 but veterinarians may not realize how common it really is. While many dog owners are aware of the condition, most don’t discuss it with their veterinarians. Canine motion sickness can prevent your whole family from taking a trip together.
Dogs with motion sickness may show a variety of signs, including:
Motion from traveling by car, plane, boat or train can affect the dog’s inner ear, which sends signals to the brain’s “vomiting center.” These signals cause your dog to show signs of motion sickness, which leads to retching (dry heaving) and
® (maropitant citrate) Tablets are the first and only FDA-approved medication to prevent vomiting due to motion sickness in dogs.
The best part: CERENIA works! In a study of dogs suffering from motion sickness, CERENIA prevented vomiting in up to 93% of cases.
CERENIA blocks the vomiting signals sent to the brain by the balance center in the inner ear. By blocking these signals, it prevents your dog from
Learn more about how CERENIA works.
Talk to your veterinarian and see if your dog can be ready to go with CERENIA!
LEARN HOW TO PREVENT VOMITING DUE TO MOTION SICKNESS IN YOUR DOG >>
IMPORTANT SAFETY INFORMATION:
Use CERENIA Tablets for prevention of vomiting due to motion sickness in
dogs 16 weeks and older. Safe use has not been evaluated in dogs with gastrointestinal obstruction, or those that have ingested toxins. Use with caution in dogs with liver dysfunction. In people, topical exposure may cause allergic skin reactions. See
full Prescribing Information.
*Approved for vomiting due to motion sickness in dogs 16 weeks of age or older.
1 Data on File. Harris Interactive Pet Owner Market Research CER MS2012. Zoetis Inc., 2012.
2 Conder GA, Sedlacek HS, Boucher JF, Clemence RG. Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs.
J Vet Pharmacol Ther. 2008 Dec;31(6):528-532.
All trademarks are the property of Zoetis Inc., its affiliates and/or its licensors.
©2014 Zoetis Inc. All rights reserved. September 2014. CER-00092
Thank you for subscribing.